Lee Kayoung, Goh Grace Ying Shyen, Wong Marcus Andrew, Klassen Tara Leah, Taubert Stefan
Graduate Program in Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
Centre for Molecular Medicine and Therapeutics and Child & Family Research Institute, University of British Columbia, Vancouver, BC, Canada.
PLoS One. 2016 Sep 12;11(9):e0162708. doi: 10.1371/journal.pone.0162708. eCollection 2016.
Nuclear hormone receptors (NHRs) are transcription factors that regulate numerous physiological and developmental processes and represent important drug targets. NHR-49, an ortholog of Hepatocyte Nuclear Factor 4 (HNF4), has emerged as a key regulator of lipid metabolism and life span in the nematode worm Caenorhabditis elegans. However, many aspects of NHR-49 function remain poorly understood, including whether and how it regulates individual sets of target genes and whether its activity is modulated by a ligand. A recent study identified three gain-of-function (gof) missense mutations in nhr-49 (nhr-49(et7), nhr-49(et8), and nhr-49(et13), respectively). These substitutions all affect the ligand-binding domain (LBD), which is critical for ligand binding and protein interactions. Thus, these alleles provide an opportunity to test how three specific residues contribute to NHR-49 dependent gene regulation. We used computational and molecular methods to delineate how these mutations alter NHR-49 activity. We find that despite originating from a screen favoring the activation of specific NHR-49 targets, all three gof alleles cause broad upregulation of NHR-49 regulated genes. Interestingly, nhr-49(et7) and nhr-49(et8) exclusively affect nhr-49 dependent activation, whereas the nhr-49(et13) surprisingly affects both nhr-49 mediated activation and repression, implicating the affected residue as dually important. We also observed phenotypic non-equivalence of these alleles, as they unexpectedly caused a long, short, and normal life span, respectively. Mechanistically, the gof substitutions altered neither protein interactions with the repressive partner NHR-66 and the coactivator MDT-15 nor the subcellular localization or expression of NHR-49. However, in silico structural modeling revealed that NHR-49 likely interacts with small molecule ligands and that the missense mutations might alter ligand binding, providing a possible explanation for increased NHR-49 activity. In sum, our findings indicate that the three nhr-49 gof alleles are non-equivalent, and highlight the conserved V411 residue affected by et13 as critical for gene activation and repression alike.
核激素受体(NHRs)是一类转录因子,可调节众多生理和发育过程,是重要的药物靶点。NHR-49是肝细胞核因子4(HNF4)的直系同源物,已成为线虫秀丽隐杆线虫脂质代谢和寿命的关键调节因子。然而,NHR-49功能的许多方面仍知之甚少,包括它是否以及如何调节各个靶基因集,以及其活性是否受配体调节。最近的一项研究在nhr-49中鉴定出三个功能获得性(gof)错义突变(分别为nhr-49(et7)、nhr-49(et8)和nhr-49(et13))。这些替换均影响配体结合域(LBD),而LBD对配体结合和蛋白质相互作用至关重要。因此,这些等位基因提供了一个机会来测试三个特定残基如何促进依赖NHR-49的基因调控。我们使用计算和分子方法来描绘这些突变如何改变NHR-49的活性。我们发现,尽管最初的筛选有利于特定NHR-49靶点的激活,但所有三个gof等位基因都会导致NHR-49调控基因的广泛上调。有趣的是,nhr-49(et7)和nhr-49(et8)仅影响依赖NHR-49的激活,而nhr-49(et13)出人意料地同时影响NHR-49介导的激活和抑制,这表明受影响的残基具有双重重要性。我们还观察到这些等位基因的表型不等效性,因为它们分别意外地导致了长、短和正常的寿命。从机制上讲,gof替换既没有改变与抑制性伴侣NHR-66和共激活因子MDT-15的蛋白质相互作用,也没有改变NHR-49的亚细胞定位或表达。然而,计算机模拟结构建模表明,NHR-49可能与小分子配体相互作用,错义突变可能改变配体结合,这为NHR-49活性增加提供了一种可能的解释。总之,我们的研究结果表明,三个nhr-49 gof等位基因是不等效的,并突出了受et13影响的保守V411残基对基因激活和抑制同样至关重要。